Clinical Trials Insight: 700039829

Trial Profile

Clinical Trials Insight: 700039829

Phase of Trial: Phase I/II

Latest Information Update: 15 Dec 2008

At a glance

  • Drugs Clofarabine; Cyclophosphamide; Etoposide
  • Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Sanofi Genzyme
  • Most Recent Events

    • 15 Dec 2008 New trial record.
    • 09 Dec 2008 Phase I and preliminary phase II results presented at the American Society of Hematology.
    • 09 Dec 2008 To date, 12 patients have been enrolled in the phase II portion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top